We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Structure of Viral Fusion Protein

By Biotechdaily staff writers
Posted on 25 Jan 2006
Virologists have used x-ray diffraction crystallography techniques to determine the structure of the parainfluenza virus fusion (F) protein in its metastable (pre-fusion) state.

Investigators at Northwestern University (Evanston, IL, USA)
stabilized the pre-fusion form of the F protein by the addition of a carboxy-terminal trimerization domain. More...
Then, they used advanced x-ray crystallography techniques to establish the structure of the F protein to a resolution of 2.85 angstroms. The details of their study were published in the January 5, 2006, issue of Nature.

The virus relies on F protein for attachment and penetration of the host cell membrane. The x-ray diffraction data showed that there were profound conformational differences between the pre- and post-fusion states, involving transformations in secondary and tertiary structure. "The protein in its metastable state has a very specific job to do--to enable infection of the cell--and it does this by essentially acting as a harpoon that shoots into the cell's membrane to bring about the fusion,” explained senior author Dr. Theodore S. Jardetzky, professor of biochemistry, molecular biology, and cell biology at Northwestern University.

"The development of antiviral drugs is helped by knowledge of the structure, shape, and mechanism of the target molecules, which is what we can now provide for the F protein,” said Dr. Jardetzky. "Knowing how the virus gets into the cell will allow us to better inhibit this key part of the viral life cycle.”






Related Links:
Northwestern University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.